April 17, 2019

IBRI announces leadership change

INDIANAPOLIS, IND. – The Indiana Biosciences Research Institute (IBRI) today announced that Rainer Fischer, Ph.D., chief executive officer (CEO) and chief scientific and innovation officer (CSIO) will step down as...

April 12, 2019

'Transformative' microscope to be installed at Purdue

WEST LAFAYETTE, IND. — The cryo-electron microscope is a modern marvel of a machine that allows scientists to look at how proteins and viruses are built atom by atom. And...

April 04, 2019

IBRI issues its digital and print 2018 Annual Report, “Discovery With Purpose”

Indianapolis, April 4, 2019 – The Indiana Biosciences Research Institute (IBRI) today announced the release of its print and digital 2018 Annual Report. The report theme is “Discovery With Purpose,”...

March 15, 2019

How Machine Learning, Simulated Data, AWS, and Virtusa Brought Innovation to Diabetes Research at the IBRI

A catalyst for innovation, a leading bioscience research institute based in the Midwest, the Indiana Bioscience Research Institute (IBRI) , is working toward its mission of becoming the first industry-inspired...

January 28, 2019

Indiana Biosciences Research Institute collaboration helps discover new genetic disease

INDIANAPOLIS, Jan. 28, 2019 -- A collaborative research project led in part by the Indiana Biosciences Research Institute (IBRI) has resulted in the first description of a new monogenic disease,...

January 16, 2019

Indiana Biosciences Research Institute and Indiana Innovation Institute form strategic alliance to collaborate on health, data and defense projects

INDIANAPOLIS, Jan. 16, 2019 – The Indiana Biosciences Research Institute (IBRI) and the Indiana Innovation Institute (IN3) today announced the formation of a strategic alliance allowing both institutes to collaborate...

January 09, 2019

Nature Medicine Publishes Local and International Companies’ Major Data Analytics Study of Type 2 Diabetes

Indianapolis, Jan. 8, 2019 – A leading scientific journal, Nature Medicine , has published a major study online on how real-world patient data can better predict diabetes-related kidney disease in...

December 12, 2018

BioCrossroads announces leadership transitions—David L. Johnson to join CICP as full-time President and CEO; Nora Doherty to serve as BioCrossroads’ interim leader

BioCrossroads announced today that after 14 years as president and CEO, David L. Johnson will leave the organization, effective December 31, 2018, to assume his responsibilities as president and CEO...

December 06, 2018

Podcast: Dr. Rainer Fischer reveals the inspiration behind the IBRI's motto, “Discovery with Purpose."

How can life science innovate like tech? How is the IBRI helping to combat the Midwestern "brain drain"?...

December 05, 2018

University of Notre Dame and Indiana Biosciences Research Institute partner to address health concerns

NOTRE DAME, Ind., Dec. 05, 2018 -- The University of Notre Dame and the Indiana Biosciences Research Institute (IBRI) have signed a strategic alliance agreement to encourage collaborations between Notre...

First ... 6 7 8 9 10  ... Last 
2019 Annual Report cover

The IBRI 2019 Annual Report is now available. The report theme is “Catalyze, Complement, Connect,” which correlates with the IBRI's goals to seek solutions for health problems, enhance the Indiana life sciences ecosystem, and expedite solutions for the most pressing health issues.